{"entity":{"id":"ionetix","kind":"company","name":"Ionetix","aka":["Ionetix Corporation","Ionetix Corp"],"tldr":"Ionetix is a Michigan company that makes radioactive isotopes with compact cyclotrons. It supplies isotopes for PET scans and produces the alpha-emitting isotopes actinium-225 and astatine-211 that newer cancer radiotherapy drugs are built on.","summary":"Ionetix Corporation, of Lansing, Michigan, incorporated in Delaware in 2009 to develop smaller superconducting cyclotrons, filed for an initial public offering in October 2026. Its cyclotrons are cryogen-free and need no liquid helium. In diagnostics it produces ammonia N-13 at nine production sites under an Abbreviated New Drug Application, and other PET isotopes including fluorine-18 and gallium-68. In therapeutics it produces the alpha-emitting isotopes actinium-225, using a cyclotron bought from a third-party maker, and astatine-211 for use in oncology therapeutics. The company says it no longer intends to sell cyclotrons.","asOf":"2026-11-04","links":[{"label":"SEC: Ionetix Form S-1/A, October 2026","url":"https://www.sec.gov/Archives/edgar/data/2108121/000121390026114512/ea0309922-s1a1_ionetix.htm"},{"label":"Official website","url":"https://www.ionetix.com/"}],"tags":[],"related":[],"cancers":[],"sections":["radiopharma","imaging"],"technologies":["actinium-225-supply","cyclotron-isotope-production","astatine-211-alpha-therapy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Read on 4 November 2026 in the S-1/A filed with the SEC on 30 October 2026. Ionetix supplies isotopes rather than medicines, so no product record is written."],"hq":"Lansing, MI","country":"US","companyType":"radiopharma","website":"https://www.ionetix.com/","founded":2009,"stage":"growth","investors":[],"funding":[]},"route":"/companies/ionetix/","neighbours":{"section":[{"id":"imaging","kind":"section","name":"Imaging","route":"/fronts/imaging/"},{"id":"radiopharma","kind":"section","name":"Radiopharmaceuticals & Theranostics","route":"/fronts/radiopharma/"}],"technology":[{"id":"actinium-225-supply","kind":"technology","name":"Actinium-225 supply: thorium stocks, accelerators and radium targets","route":"/technologies/actinium-225-supply/"},{"id":"astatine-211-alpha-therapy","kind":"technology","name":"Astatine-211 alpha therapy","route":"/technologies/astatine-211-alpha-therapy/"},{"id":"cyclotron-isotope-production","kind":"technology","name":"Cyclotron isotope production (F-18, Ga-68, Cu-64, Zr-89, At-211)","route":"/technologies/cyclotron-isotope-production/"}]}}